Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Itb-Med AB
Sponsor

Itb-Med AB

Sweden Hagaplan 4, 113 68 Stockholm, Sweden

About the sponsor

Itb-Med AB funds clinical research in renal transplantation and liver transplantation, with a strong focus on preventing graft rejection and supporting immune compatibility after organ replacement.

  • Kidney transplant rejection prevention
  • Liver allograft tolerance
  • Allogeneic immune regulation

The sponsor’s transplant portfolio centers on immunomodulatory therapy in recipients of deceased-donor organs and other post-transplant settings.

About Specializations

Itb-Med AB runs clinical trials in conditions such as Prophylaxis against transplant rejection, Type 1 diabetes mellitus, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Prophylaxis against transplant rejection

Not yet recruiting
InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Siplizumab
  • Sponsor:Itb-Med AB

Prophylaxis against transplant rejection

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Itb-Med AB

Type 1 diabetes mellitus

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Paracetamol
  • Sponsor:Itb-Med AB

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.